Javascript must be enabled to continue!
Syk expression in non-small-cell lung cancer and its relation with angiogenesis
View through CrossRef
Objective:
To study the expression of spleentyrosine kinase (Syk) gene in non--small--cell lung cancer and the relationship between Syk mRNA and microvessel density (MVD) in the tumor cells.
Materials and Methods:
The expression of Syk gene in 70 cases of lung tumor tissues, adjacent tissues, and normal lung tissues were examined with reverse transcription polymerase chain reaction (RT--PCR). The expression of MVD was examined with immunohistochemical streptavidin--biotin complex (SABC). The relation between them was analyzed.
Results:
Syk mRNA expression rates were 5.7, 95.7, and 100% in tumor, adjacent lung cells, and normal lung cells, respectively. The expression rate in tumor cells was significantly lower compared with those in normal lung tissue and adjacent lung tissue (
P
< 0.05), expression rate among different pathologic types, differentiation and clinical stages did not reveal any statistically significant differences (
P
> 0.05). The positive rate of CD34 in tumor was higher than that in adjacent tissues and normal lung tissues. The expression of Syk mRNA and MVD were negatively correlated.
Conclusions:
The lack of Syk mRNA expression in lung cancer play an important role in angiogenesis.
Ovid Technologies (Wolters Kluwer Health)
Title: Syk expression in non-small-cell lung cancer and its relation with angiogenesis
Description:
Objective:
To study the expression of spleentyrosine kinase (Syk) gene in non--small--cell lung cancer and the relationship between Syk mRNA and microvessel density (MVD) in the tumor cells.
Materials and Methods:
The expression of Syk gene in 70 cases of lung tumor tissues, adjacent tissues, and normal lung tissues were examined with reverse transcription polymerase chain reaction (RT--PCR).
The expression of MVD was examined with immunohistochemical streptavidin--biotin complex (SABC).
The relation between them was analyzed.
Results:
Syk mRNA expression rates were 5.
7, 95.
7, and 100% in tumor, adjacent lung cells, and normal lung cells, respectively.
The expression rate in tumor cells was significantly lower compared with those in normal lung tissue and adjacent lung tissue (
P
< 0.
05), expression rate among different pathologic types, differentiation and clinical stages did not reveal any statistically significant differences (
P
> 0.
05).
The positive rate of CD34 in tumor was higher than that in adjacent tissues and normal lung tissues.
The expression of Syk mRNA and MVD were negatively correlated.
Conclusions:
The lack of Syk mRNA expression in lung cancer play an important role in angiogenesis.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Evaluation of SYK protein expression in treated versus untreated retinoblastoma
Evaluation of SYK protein expression in treated versus untreated retinoblastoma
Introduction
Retinoblastoma is the most common intraocular malignancy in infants and children younger than 5 years. If untreated, retinob...
Functional and transcriptomic changes in synergy of endotoxin and (1->3)-β-D-glucan in bone marrow derived macrophage from Fc gamma receptor IIb deficient mice
Functional and transcriptomic changes in synergy of endotoxin and (1->3)-β-D-glucan in bone marrow derived macrophage from Fc gamma receptor IIb deficient mice
Systemic lupus erythematosus (SLE) is an autoimmune disease with a diverse array of clinical symptoms. There are many factors including environmental factors may trigger disease pr...
Differential Mast Cell Outcomes Are Sensitive to FcεRI-Syk Binding Kinetics
Differential Mast Cell Outcomes Are Sensitive to FcεRI-Syk Binding Kinetics
Abstract
Crosslinking of IgE-bound FcεRI triggers multiple cellular responses, including degranulation and cytokine production. Signaling is dependent on recruitmen...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1
The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1
Abstract
Background
N6-methyladenosine (m6A) is the most common posttranscriptional modification of RNA and plays critical roles in human cancer pro...
Molecular aspects of multivalent engagement between Syk and FcεRIγ
Molecular aspects of multivalent engagement between Syk and FcεRIγ
ABSTRACT
Syk/Zap70 family kinases are essential for signaling via multichain immune-recognition receptors such as the tetrameric (αβγ2) FcεRI The...
RNA Demethylase ALKBH5 Promotes Progression and Angiogenesis of Lung Cancer via Regulating the Stability of LncRNA PVT1
RNA Demethylase ALKBH5 Promotes Progression and Angiogenesis of Lung Cancer via Regulating the Stability of LncRNA PVT1
Abstract
Background
N6-methyladenosine (m6A) is the most common posttranscriptional modification of RNA and plays critical roles in human cancer progression. However, biol...

